Skip to content

Parkinson's Disease and Movement Disorders Clinical Database

Parkinson's Disease and Movement Disorders Clinical Database

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04997642
Enrollment
250
Registered
2021-08-09
Start date
2019-09-30
Completion date
2029-09-15
Last updated
2025-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lewy Body Dementia With Behavioral Disturbance, Lewy Body Parkinson Disease, Parkinson Disease, Parkinson Disease Dementia

Brief summary

The research database contains demographic and family history information, longitudinal information on the clinical symptoms, neuropsychological profile and treatments, stored biological samples, and brain images of patients with Parkinson's disease and related disorders receiving care at the Parkinson's disease and Movement Disorders Center and the Hospital of the University of Pennsylvania.

Detailed description

The research database contains demographic and family history information, longitudinal information on the clinical symptoms, neuropsychological profile and treatments, stored biological samples, and brain images of patients with Parkinson's disease and related disorders receiving care at the Parkinson's disease and Movement Disorders Center (PDMDC) and the Hospital of the University of Pennsylvania. The purpose of the research database is to have a comprehensive source of data that can be used for educational, research and patient care projects at the PDMDC. These data may be used for any study examining the relationship between treatment and clinical symptoms of patients with PD and related disorders. The main uses of the data are to: * Determine the long term effects of Parkinson's disease and related conditions, including predictors of its motor and non-motor symptoms * Identify genetic and other neurobiological factors related to the risk of developing Parkinson's disease and related disorders and their course * Improve our understanding of how best to identify, diagnose, and manage motor and non-motor symptoms of Parkinson's disease and related conditions Evaluate biological markers of disease or response to therapy * Identify patients who may be candidates for participation in trials of new medications. * Identify patients who may be interested in participating in educational or developmental activities Participants are seen annually for the first 4 years, biennially thereafter. The participants continue in the study until study end, withdrawal, or death on study.

Interventions

BEHAVIORALneuropsychiatric and cognitive testing questionnaires

Demographic data such as race, sex, age Family History Risk Factor Questionnaire Hoehn and Yahr Stage UPDRS Parkinson's symptom checklist Medication list Neuropsychological Test Battery Behavioral Exams * Geriatric Depression Scale Quality of Life Questionnaire * PDQ-39, SF-12

Sponsors

National Institute on Aging (NIA)
CollaboratorNIH
University of Pennsylvania
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Any person who receives medical care for the diagnosis of Parkinson's disease with mild cognitive impairment (MCI) or dementia may be eligible to participate in the research database. There are no limitations for database participation based on age, disease severity or presence of cognitive impairments, as long as the person is able to complete the research assessments.

Exclusion criteria

Absence of Parkinson's disease diagnosis. There are no limitations for database participation based on age, disease severity or presence of cognitive impairments, as long as the person is able to complete the research assessments.

Design outcomes

Primary

MeasureTime frameDescription
Long term effects of Parkinson's disease5 yearsDetermine the long term effects of Parkinson's disease and related conditions, including predictors of its motor and non-motor symptoms
Genetic and Neurobiological factors5 yearsIdentify genetic and other neurobiological factors related to the risk of developing Parkinson's disease and related disorders and their course

Secondary

MeasureTime frameDescription
Identification and Diagnosis of Parkinson's disease5 yearsImprove our understanding of how best to identify, diagnose, and manage motor and non-motor symptoms of Parkinson's disease and related conditions

Countries

United States

Contacts

Primary ContactEugenia Mamikonyan
eugenia.mamikonyan@pennmedicine.upenn.edu215-615-3085

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026